Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
77 studies found for:    Open Studies | "Erectile Dysfunction"
Show Display Options
Rank Status Study
21 Recruiting Low Energy Shockwave Therapy for Improving Erectile Dysfunction
Condition: Erectile Dysfunction
Interventions: Other: Pre-inclusion questionnaires;   Drug: 1 month of PDE5i treatment;   Other: PDE5i follow-up questionnaires;   Other: Inclusion questionnaires;   Device: 4 weekly LIESWT (Wave 1) with the RENOVA device;   Device: 4 weekly sham LIESWT (Wave 1) with the RENOVA device;   Other: Follow-up questionnaires 1 month after Wave 1;   Other: Follow-up questionnaires 3 months after Wave 1;   Device: 8 bi-weekly LIESWT (Wave 2) with the RENOVA device;   Other: Follow-up questionnaires 1 month after Wave 2;   Other: Questionnaires via postal mail;   Other: Final follow-up questionnaires 12 months after Wave 2
22 Recruiting Sagene 2014 - Parkinson's Disease and Erectile Dysfunction
Conditions: Parkinson's Disease;   Erectile Dysfunction
Interventions: Drug: Selegiline;   Drug: Tadalafil
23 Unknown  Low Intensity Extracorporeal Shock Wave Therapy for the Treatment of Erectile Dysfunction- 4 Arms
Condition: Erectile Dysfunction
Intervention: Device: Extracorporeal Shockwave Therapy Generator (Omnispec ED1000)
24 Not yet recruiting Safety and Clinical Efficacy of Local Topical Treatment for Erectile Dysfunction
Condition: Erectile Dysfunction
Intervention: Drug: VL#FIA3-30
25 Recruiting Evaluation of Advanced Glycation End-products (AGE) and the Erectile Dysfunction (DE) in Diabetic Patients
Conditions: Diabetes Mellitus, Non-Insulin-Dependent;   Erectile Dysfunction
Interventions: Other: DE assessment;   Other: AGE measurement
26 Recruiting Safety of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Erectile Dysfunction
Condition: Erectile Dysfunction
Intervention: Drug: mesenchymal stem cell (Cellgram-ED)
27 Not yet recruiting Low Frequency Shock Wave Therapy for Improving Post-prostatectomy Erectile Dysfunction: a Prospective Pilot Study
Condition: Erectile Dysfunction
Intervention: Device: 8 bi-weekly LIESWT sessions
28 Recruiting Impact of a Sexology Consultation on Disease Control of Type 2 Male Diabetics With Erectile Dysfunction
Conditions: Erectile Dysfunction;   Type 2 Diabetes
Intervention: Procedure: Sexology consultation
29 Recruiting Safety and Efficacy of TD0025 (Rocket1h) for Treatment of Erectile Dysfunction
Condition: Erectile Dysfunction
Interventions: Drug: TD0025;   Drug: Sildenafil Citrate 50mg
30 Unknown  Uroxatral in Men With Benign Prostate Hypertrophy (BPH) and Erectile Dysfunction (ED)
Conditions: BPH;   Erectile Dysfunction
Intervention: Drug: Alfuzosin 10 mg
31 Not yet recruiting Bioabsorbable Everolimus-Eluting Stents for Internal Pudendal Artery-Related Arteriogenic Erectile Dysfunction
Condition: Impotence, Arteriogenic
Intervention: Device: Bioabsorbable everolimus-eluting stent deployment
32 Recruiting Clinical Trial of Topically-applied Glyceryl Trinitrate (GTN) for the Treatment of Erectile Dysfunction (ED)
Condition: Erectile Dysfunction
Interventions: Drug: Glyceryl trinitrate;   Drug: MED Placebo
33 Recruiting A Phase 2a, Single-Dose, Double-Blind, Placebo-Controlled, 2-Way Crossover Study Using Penile Plethysmography to Evaluate the Efficacy and Safety of SST-6006, a Topical Sildenafil Cream (5% w/w), Compared to Placebo in the Treatment of Erectile Dysfunction
Condition: Erectile Dysfunction
Interventions: Drug: Sildenafil;   Drug: Placebo
34 Unknown  The Incidence and Treatment of Insulin Resistance Among Men With Erectile Dysfunction
Conditions: Erectile Dysfunction;   Metabolic Syndrome;   Insulin Resistance
Intervention:
35 Unknown  Efficacy and Safety of Tadalafil in Hemodialysis Patients
Condition: Erectile Dysfunction
Intervention: Drug: tadalafil
36 Unknown  Nebivolol Effects on Endothelial Function and Erectile Function
Condition: Erectile Dysfunction
Interventions: Drug: Nebivolol;   Drug: Sugar Pill
37 Unknown  Low Intensity ShockWave Therapy for ED in Non Responders to PDE5i - a Double Blind Placebo Controlled Study
Condition: Erectile Dysfunction
Interventions: Device: Extracorporeal Shockwave Therapy Generator (Vascuspec);   Device: Low intensity shock wave therapy
38 Recruiting Management of Peyronie's Disease With Adipose Tissue Stem Cell
Conditions: Erectile Dysfunction;   Peyronie' Disease
Intervention: Drug: Adipose tissue stem cell injection
39 Recruiting Preservation of Endopelvic Fascia: Effects on Postoperative Incontinence and Impotence. Randomized Clinical Trial.
Conditions: Prostatic Neoplasms;   Urinary Incontinence;   Erectile Dysfunction
Interventions: Procedure: Preservation (endopelvic fascia);   Procedure: Opening (endopelvic fascia)
40 Unknown  Periodontal Disease as a Risk Indicator for Erectile Dysfunction - A Cross-sectional Study on 100 Patients
Conditions: Erectile Dysfunction;   Periodontitis;   hsCRP
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years